Implantable Cardioverter Defibrillators Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Transvenous Implantable Cardioverter Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators, and Cardiac Resynchronization Therapy Defibrillator (CRT-D)); End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others), and Geography

Report Code: TIPMD00002563 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

An implantable cardioverter defibrillator (ICD) is a battery-powered device that is implanted under the skin that monitors the heart rate in patients who have prolonged tachycardia or fibrillation. In individuals with persistent ventricular tachycardia or fibrillation, such devices can help prevent impulsive deaths. Implantable cardioverter defibrillator devices are also known to play an important role in preventing cardiac arrest in patients with a history of cardiac arrest or tachycardia associated with a pulseless ventricle.

MARKET SCOPE

The "Global Implantable Cardioverter Defibrillators Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of the implantable cardioverter defibrillators market with detailed market segmentation by product, end user, and geography. The report provides key statistics on the market status of the leading implantable cardioverter defibrillators market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on product, the global implantable cardioverter defibrillators market is segmented into transvenous implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, and cardiac resynchronization therapy defibrillator (CRT-D). The transvenous implantable cardioverter defibrillators is further segmented into biventricular implantable cardioverter defibrillators, single chambered, and dual chambered.
  •   Based on end user, the market is bifurcated into hospitals, specialty clinics, ambulatory surgical centers, and others

MARKET DYNAMICS
Drivers

  •   Increase in adoption of S-ICDs
  •   Emergence of new technologies

Restraints

  •   Risk associted with these procedures

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The implantable cardioverter defibrillators market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the implantable cardioverter defibrillators market in these regions.

IMPACT OF COVID-19 ON IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the implantable cardioverter defibrillators market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from implantable cardioverter defibrillators market are anticipated to lucrative growth opportunities in the future with the rising demand for implantable cardioverter defibrillators in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the implantable cardioverter defibrillators market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Medtronic
  •   Abbott
  •   Boston Scientific Corporation
  •   Koninklijke Philips N.V.
  •   ZOLL Medical Corporation
  •   Physio-Control Inc
  •   NIHON KOHDEN CORPORATION
  •   Pacetronix
  •   EBR Systems Inc.
  •   MEDICO S.p.A.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Implantable Cardioverter Defibrillators Market - By Product
1.3.2 Implantable Cardioverter Defibrillators Market - By End User
1.3.3 Implantable Cardioverter Defibrillators Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET - GLOBAL MARKET ANALYSIS
6.1. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS - GLOBAL MARKET OVERVIEW
6.2. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
7.3.1. Overview
7.3.2. Transvenous Implantable Cardioverter Defibrillators Market Forecast and Analysis
7.3.3. Biventricular Implantable Cardioverter Defibrillators Market
7.3.3.1. Overview
7.3.3.2. Biventricular Implantable Cardioverter Defibrillators Market Forecast and Analysis
7.3.4. Single Chambered Market
7.3.4.1. Overview
7.3.4.2. Single Chambered Market Forecast and Analysis
7.3.5. Dual Chambered Market
7.3.5.1. Overview
7.3.5.2. Dual Chambered Market Forecast and Analysis
7.4. SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
7.4.1. Overview
7.4.2. Subcutaneous Implantable Cardioverter Defibrillators Market Forecast and Analysis
7.5. CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D)
7.5.1. Overview
7.5.2. Cardiac Resynchronization Therapy Defibrillator (CRT-D) Market Forecast and Analysis
8. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. SPECIALTY CLINICS
8.4.1. Overview
8.4.2. Specialty Clinics Market Forecast and Analysis
8.5. AMBULATORY SURGICAL CENTERS
8.5.1. Overview
8.5.2. Ambulatory Surgical Centers Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Implantable Cardioverter Defibrillators Market Overview
9.1.2 North America Implantable Cardioverter Defibrillators Market Forecasts and Analysis
9.1.3 North America Implantable Cardioverter Defibrillators Market Forecasts and Analysis - By Product
9.1.4 North America Implantable Cardioverter Defibrillators Market Forecasts and Analysis - By End User
9.1.5 North America Implantable Cardioverter Defibrillators Market Forecasts and Analysis - By Countries
9.1.5.1 United States Implantable Cardioverter Defibrillators Market
9.1.5.1.1 United States Implantable Cardioverter Defibrillators Market by Product
9.1.5.1.2 United States Implantable Cardioverter Defibrillators Market by End User
9.1.5.2 Canada Implantable Cardioverter Defibrillators Market
9.1.5.2.1 Canada Implantable Cardioverter Defibrillators Market by Product
9.1.5.2.2 Canada Implantable Cardioverter Defibrillators Market by End User
9.1.5.3 Mexico Implantable Cardioverter Defibrillators Market
9.1.5.3.1 Mexico Implantable Cardioverter Defibrillators Market by Product
9.1.5.3.2 Mexico Implantable Cardioverter Defibrillators Market by End User
9.2. EUROPE
9.2.1 Europe Implantable Cardioverter Defibrillators Market Overview
9.2.2 Europe Implantable Cardioverter Defibrillators Market Forecasts and Analysis
9.2.3 Europe Implantable Cardioverter Defibrillators Market Forecasts and Analysis - By Product
9.2.4 Europe Implantable Cardioverter Defibrillators Market Forecasts and Analysis - By End User
9.2.5 Europe Implantable Cardioverter Defibrillators Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Implantable Cardioverter Defibrillators Market
9.2.5.1.1 Germany Implantable Cardioverter Defibrillators Market by Product
9.2.5.1.2 Germany Implantable Cardioverter Defibrillators Market by End User
9.2.5.2 France Implantable Cardioverter Defibrillators Market
9.2.5.2.1 France Implantable Cardioverter Defibrillators Market by Product
9.2.5.2.2 France Implantable Cardioverter Defibrillators Market by End User
9.2.5.3 Italy Implantable Cardioverter Defibrillators Market
9.2.5.3.1 Italy Implantable Cardioverter Defibrillators Market by Product
9.2.5.3.2 Italy Implantable Cardioverter Defibrillators Market by End User
9.2.5.4 Spain Implantable Cardioverter Defibrillators Market
9.2.5.4.1 Spain Implantable Cardioverter Defibrillators Market by Product
9.2.5.4.2 Spain Implantable Cardioverter Defibrillators Market by End User
9.2.5.5 United Kingdom Implantable Cardioverter Defibrillators Market
9.2.5.5.1 United Kingdom Implantable Cardioverter Defibrillators Market by Product
9.2.5.5.2 United Kingdom Implantable Cardioverter Defibrillators Market by End User
9.2.5.6 Rest of Europe Implantable Cardioverter Defibrillators Market
9.2.5.6.1 Rest of Europe Implantable Cardioverter Defibrillators Market by Product
9.2.5.6.2 Rest of Europe Implantable Cardioverter Defibrillators Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Implantable Cardioverter Defibrillators Market Overview
9.3.2 Asia-Pacific Implantable Cardioverter Defibrillators Market Forecasts and Analysis
9.3.3 Asia-Pacific Implantable Cardioverter Defibrillators Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Implantable Cardioverter Defibrillators Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Implantable Cardioverter Defibrillators Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Implantable Cardioverter Defibrillators Market
9.3.5.1.1 Australia Implantable Cardioverter Defibrillators Market by Product
9.3.5.1.2 Australia Implantable Cardioverter Defibrillators Market by End User
9.3.5.2 China Implantable Cardioverter Defibrillators Market
9.3.5.2.1 China Implantable Cardioverter Defibrillators Market by Product
9.3.5.2.2 China Implantable Cardioverter Defibrillators Market by End User
9.3.5.3 India Implantable Cardioverter Defibrillators Market
9.3.5.3.1 India Implantable Cardioverter Defibrillators Market by Product
9.3.5.3.2 India Implantable Cardioverter Defibrillators Market by End User
9.3.5.4 Japan Implantable Cardioverter Defibrillators Market
9.3.5.4.1 Japan Implantable Cardioverter Defibrillators Market by Product
9.3.5.4.2 Japan Implantable Cardioverter Defibrillators Market by End User
9.3.5.5 South Korea Implantable Cardioverter Defibrillators Market
9.3.5.5.1 South Korea Implantable Cardioverter Defibrillators Market by Product
9.3.5.5.2 South Korea Implantable Cardioverter Defibrillators Market by End User
9.3.5.6 Rest of Asia-Pacific Implantable Cardioverter Defibrillators Market
9.3.5.6.1 Rest of Asia-Pacific Implantable Cardioverter Defibrillators Market by Product
9.3.5.6.2 Rest of Asia-Pacific Implantable Cardioverter Defibrillators Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Implantable Cardioverter Defibrillators Market Overview
9.4.2 Middle East and Africa Implantable Cardioverter Defibrillators Market Forecasts and Analysis
9.4.3 Middle East and Africa Implantable Cardioverter Defibrillators Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Implantable Cardioverter Defibrillators Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Implantable Cardioverter Defibrillators Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Implantable Cardioverter Defibrillators Market
9.4.5.1.1 South Africa Implantable Cardioverter Defibrillators Market by Product
9.4.5.1.2 South Africa Implantable Cardioverter Defibrillators Market by End User
9.4.5.2 Saudi Arabia Implantable Cardioverter Defibrillators Market
9.4.5.2.1 Saudi Arabia Implantable Cardioverter Defibrillators Market by Product
9.4.5.2.2 Saudi Arabia Implantable Cardioverter Defibrillators Market by End User
9.4.5.3 U.A.E Implantable Cardioverter Defibrillators Market
9.4.5.3.1 U.A.E Implantable Cardioverter Defibrillators Market by Product
9.4.5.3.2 U.A.E Implantable Cardioverter Defibrillators Market by End User
9.4.5.4 Rest of Middle East and Africa Implantable Cardioverter Defibrillators Market
9.4.5.4.1 Rest of Middle East and Africa Implantable Cardioverter Defibrillators Market by Product
9.4.5.4.2 Rest of Middle East and Africa Implantable Cardioverter Defibrillators Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Implantable Cardioverter Defibrillators Market Overview
9.5.2 South and Central America Implantable Cardioverter Defibrillators Market Forecasts and Analysis
9.5.3 South and Central America Implantable Cardioverter Defibrillators Market Forecasts and Analysis - By Product
9.5.4 South and Central America Implantable Cardioverter Defibrillators Market Forecasts and Analysis - By End User
9.5.5 South and Central America Implantable Cardioverter Defibrillators Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Implantable Cardioverter Defibrillators Market
9.5.5.1.1 Brazil Implantable Cardioverter Defibrillators Market by Product
9.5.5.1.2 Brazil Implantable Cardioverter Defibrillators Market by End User
9.5.5.2 Argentina Implantable Cardioverter Defibrillators Market
9.5.5.2.1 Argentina Implantable Cardioverter Defibrillators Market by Product
9.5.5.2.2 Argentina Implantable Cardioverter Defibrillators Market by End User
9.5.5.3 Rest of South and Central America Implantable Cardioverter Defibrillators Market
9.5.5.3.1 Rest of South and Central America Implantable Cardioverter Defibrillators Market by Product
9.5.5.3.2 Rest of South and Central America Implantable Cardioverter Defibrillators Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, KEY COMPANY PROFILES
12.1. MEDTRONIC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ABBOTT
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BOSTON SCIENTIFIC CORPORATION
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. KONINKLIJKE PHILIPS N.V.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ZOLL MEDICAL CORPORATION
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. PHYSIO-CONTROL INC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NIHON KOHDEN CORPORATION
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PACETRONIX
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. EBR SYSTEMS INC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. MEDICO S.P.A.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Medtronic
2. Abbott
3. Boston Scientific Corporation
4. Koninklijke Philips N.V.
5. ZOLL Medical Corporation
6. Physio-Control Inc.
7. NIHON KOHDEN CORPORATION
8. Pacetronix
9. EBR Systems Inc
10. MEDICO S.p.A.
11. MicroPort Scientific Corporation
12. Imricor Medical Systems, Inc.
13. LivaNova PLC Company
14. Mayo Clinic US
15. Jude Medical, Inc.
16. MRI Interventions, Inc.
TIPMD00002563
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking